Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of the Rivastigmine Patch on Attention and Behavior in Parkinson's Disease With Dementia (PDD)

NCT00988117 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00988117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00988117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of the Rivastigmine Patch on Attention and Behavior in Parkinson's Disease With Dementia (PDD)
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
April 30, 2011
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinsons disease with dementia, parkinsons disease with mild to moderate memory and/or thinking problems